Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017
C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
Ziprasidone versus other atypical antipsychotics for schizophrenia
K Komossa, C Rummel‐Kluge… - Cochrane Database …, 2009 - cochranelibrary.com
Background In many countries of the industrialised world second generation ('atypical')
antipsychotics have become the first line drug treatment for people with schizophrenia. The …
antipsychotics have become the first line drug treatment for people with schizophrenia. The …
Addressing structural racism in psychiatry with steps to improve psychophysiologic research
Importance The American Medical Association has acknowledged the public health threat
posed by racism in medicine. While clinicians in psychiatry have echoed the sentiment, the …
posed by racism in medicine. While clinicians in psychiatry have echoed the sentiment, the …
Nicotine and Opioids: a Call for Co-treatment as the Standard of Care
CD Morris, CE Garver-Apgar - The journal of behavioral health services & …, 2020 - Springer
The US is in the midst of an opioid epidemic. At the same time, tobacco use remains the
leading cause of preventable death and disability. While the shared biological …
leading cause of preventable death and disability. While the shared biological …
Perphenazine for schizophrenia
Background Perphenazine is an old phenothiazine antipsychotic with a potency similar to
haloperidol. It has been used for many years and is popular in the northern European …
haloperidol. It has been used for many years and is popular in the northern European …
Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations
Leishmaniasis is a neglected tropical disease caused by Leishmania parasites and is
associated to more than 1.3 million cases annually. Some of the pharmacological options for …
associated to more than 1.3 million cases annually. Some of the pharmacological options for …
Impact of CYP2D6 on serum concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol
RB Waade, V Solhaug, G Høiseth - British Journal of Clinical …, 2021 - Wiley Online Library
Aims To investigate the impact of cytochrome P450 2D6 (CYP2D6) on dose‐adjusted serum
concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol in a therapeutic …
concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol in a therapeutic …
Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine
G Bruni, L Maggi, L Tammaro, R Di Lorenzo… - International journal of …, 2016 - Elsevier
Solubility represents an important challenge for formulation of drugs, because the
therapeutic efficacy of a drug depends on the bioavailability and ultimately on its solubility …
therapeutic efficacy of a drug depends on the bioavailability and ultimately on its solubility …
Effect of smoking on risperidone pharmacokinetics–a multifactorial approach to better predict the influence on drug metabolism
G Schoretsanitis, E Haen, B Stegmann, C Hiemke… - Schizophrenia …, 2017 - Elsevier
Purpose To disentangle an association between tobacco smoking, smoking habits and
pharmacokinetic patterns such as plasma concentrations of risperidone (RIS), its active …
pharmacokinetic patterns such as plasma concentrations of risperidone (RIS), its active …
Comparison of Efficacy and Safety between Long‐Acting Injectable Antipsychotic Monotherapy and Combination of Long‐Acting Injectable and Oral Antipsychotics in …
T Sathienluckana, P Tiangpattanawong… - Schizophrenia …, 2021 - Wiley Online Library
Background. Long‐acting injectable (LAI) antipsychotics are used as a monotherapy in
patients with schizophrenia. However, the combination of LAI and oral antipsychotics is …
patients with schizophrenia. However, the combination of LAI and oral antipsychotics is …